Clinical Study

Pregabalin for Refractory Radicular Leg Pain due to Lumbar Spinal Stenosis: A Preliminary Prospective Study

Table 3

Adverse events.

Age/sexEventPGB dose at onset
(mg/day)
Onset
(days after PGB prescription)
SeverityCausal associationPGB prescriptionSpecial treatment

76/MRash25 mg 1
(25)
5MildUnclearWithdrawnNo
76/FDizziness25 mg 2
(50)
14MildYesWithdrawnNo
79/MNausea50 mg 2
(100)
30Mod.YesWithdrawnNo
79/MAtaxia50 mg 2
(100)
30Mod.YesWithdrawnNo
79/MSomnolentia25 mg 2
(50)
10MildNoDose decreasedNo
81/MIncreased numbness75 mg 2
(150)
25Mod.UnclearWithdrawnNo
82/MIncreased numbness25 mg 1
(25)
14Mod.UnclearWithdrawnNo
78/FFever75 mg 2
(150)
33Mod.UnclearWithdrawnNo
(blood test)
78/FNausea75 mg 2
(150)
33Mod.UnclearWithdrawnNo
64/FAtaxia50 mg 2
(100)
14Mod.YesDose decreasedNo
64/FDizziness50 mg 2
(100)
14Mod.YesDose decreasedNo
64/FNausea50 mg 2
(100)
14Mod.YesDose decreasedNo
64/MRash25 mg 1
(25)
6Mod.UnclearWithdrawnNo
71/FSomnolentia25 mg 2
(50)
16MildYesContinuedNo
71/FAtaxia25 mg 2
(50)
16MildYesContinuedNo
54/FWeight gain231UnclearWithdrawn
73/FEdema140MildYesDose decreasedNo
74/MEdema150 mg 2
(300)
35MildYesDose decreasedNo

Mod.: moderate.